News

ZoomMed claimed that ZRx Prescriber application turns out to be a valuable tool for the Canadian Pharmaceutical Industry. ZRx Prescriber enables physicians to use a wireless device, such

Cimzia is indicated for reducing the signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had

Immucor claimed that NEO is designed to increase productivity, performance and flexibility of high volume laboratories. NEO delivers type-and-screen throughput and broadest test menu as well as new

The grant is expected to be used to fund the study of mechanisms of cellular reprogramming with the specific aim of enhancing the efficiency of reprogramming techniques. Through

Panacea Biotec’s pharmaceutical formulation facility, spanning over 10,925m2, has blocks for oral solids, semi-solids and liquid oral dosage forms. The oral dosage form block has capability to manufacture

Dow Chemical has posted a net income of $552m for the first quarter 2010, or $0.41 per diluted share, compared to $35m, or $0.03 per diluted share, for

Wyatt Technology said that DynaPro facilitated the detection of aggregation in early stages of micellisation of pluronic polymeric surfactant due to temperature effects, pH, salinity concentration and composition.

As per the terms of the agreement, Protox is expected to receive an upfront payment of $3m and is eligible to receive a near term milestone payment of

Allergan has posted a net income of $169m for the first quarter of 2010, compared to $45m for the prior year period. Operating income was $250.3m, compared to